Abby Lauren Olsen

Well-versed in the complexities of neurological disorders, Abby Lauren Olsen serves as an Assistant Professor of Neurology at the University of Pittsburgh-Bradford. She is a distinguished alumna of Carleton College and earned her MD and PhD from the University of Pennsylvania. Dr. Olsen's research is primarily centered on the exploration of glial genes and their role in the pathogenesis of Parkinson’s disease and other alpha-synucleinopathies. Her work is pivotal in advancing the understanding of how these genes influence the development and progression of neurodegenerative diseases. Dr. Olsen is deeply committed to the clinical care of patients suffering from Parkinson’s disease and Parkinson’s Plus syndromes. Her dedication to patient care is matched by her passion for research, where she employs innovative animal models to unravel the complexities of glial involvement in neurological disorders. Her research not only aims to identify potential therapeutic targets but also seeks to improve the quality of life for those affected by these debilitating conditions. Throughout her career, Dr. Olsen has been recognized for her contributions to the field of neurology. She has received numerous accolades, including the prestigious NIH Loan Repayment Award, the NINDS K08 award, and the George C. Cotzias Memorial Fellowship from the American Parkinson’s Disease Association. These honors underscore her commitment to advancing medical knowledge and improving patient outcomes. In addition to her research and clinical responsibilities, Dr. Olsen is actively involved in mentoring the next generation of neurologists and researchers. She is dedicated to fostering an environment of learning and discovery, encouraging her students and colleagues to push the boundaries of current neurological research. Dr. Olsen's work continues to inspire and influence the field of neurology, as she remains at the forefront of research into glial genes and their impact on neurodegenerative diseases. Her contributions are not only shaping the future of neurological research but also providing hope for patients and families affected by these challenging conditions.